The Bob Harrington Show

Do cardiologists from the AFFIRM generation treat AF less aggressively than the EAST-AFNET generation? Bob Harrington and Jonathan Piccini discuss this and upcoming trials on atrial fibrillation. This podcast is intended for healthcare professionals only. To read a transcript or to comment, visit: https://www.medscape.com/author/bob-harrington A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation (AFFIRM) https://www.nejm.org/doi/full/10.1056/NEJMoa021328 Early Rhythm-Control Therapy in Patients with Atrial Fibrillation (EAST-AFNET 4) https://www.nejm.org/doi/10.1056/NEJMoa2019422 Early AF Rhythm-Control Advantage Climbs With Comorbidity Burden: EAST-AFNET4 https://www.medscape.com/viewarticle/979627 Early Dronedarone Versus Usual Care to Improve Outcomes in Persons With Newly Diagnosed Atrial Fibrillation (CHANGE-AFIB) https://clinicaltrials.gov/ct2/show/NCT05130268 Generalizability of the EAST‐AFNET 4 Trial: Assessing Outcomes of Early Rhythm‐Control Therapy in Patients With A